Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Spondyloarthritis
Author(s) -
Daniel Wendling,
Clément Prati
Publication year - 2017
Publication title -
immunotherapy
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.127
H-Index - 48
eISSN - 1750-7448
pISSN - 1750-743X
DOI - 10.2217/imt-2017-0001
Subject(s) - medicine , enthesitis , psoriatic arthritis , dactylitis , ankylosing spondylitis , nonsteroidal , antirheumatic drugs , inflammatory bowel disease , dermatology , psoriasis , certolizumab pegol , sacroiliitis , arthritis , disease , infliximab , antirheumatic agents
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom